Cefuroxime PO for Bacteremic UTI
Cefuroxime PO for Bacteremic UTI The available pharmacokinetic-pharmacodynamic data supports cefuroxime as a PO step-down option in patients with complicated urinary tract infections with secondary bacteremia. True or False? How did others respond? Reveal the answer Best Answer False Explanation: At a dose of 500 mg BID, good pharmacokinetic-pharmacodynamic target attainment may be only achieved …
